-
Anti-ROR1 Antibody (Zilovertamab): Advancing Functional Canc
2026-05-16
Explore how Anti-ROR1 Antibody (Zilovertamab) empowers functional assays and translational cancer research by enabling precise Wnt5a-induced ROR1 signaling inhibition. This article uniquely bridges molecular mechanism, practical assay optimization, and emerging insights from mitophagy research.
-
Tunable Human Intestinal Organoid System Enables Balanced Se
2026-05-15
This study presents a robust protocol for generating human intestinal organoids with enhanced cellular diversity and proliferative capacity, overcoming longstanding limitations in balancing stem cell self-renewal and differentiation. By systematically modulating key signaling pathways with small molecules, the authors establish a scalable and tunable culture platform with significant implications for organoid-based research and high-throughput applications.
-
FerroOrange: Fe²⁺ Fluorescent Probe for Live Cell Iron Detec
2026-05-15
FerroOrange empowers researchers with real-time, selective detection of intracellular Fe²⁺, enabling high-resolution iron metabolism and ferroptosis studies. Its streamlined protocol, live-cell specificity, and compatibility with fluorescence microscopy and flow cytometry offer unmatched flexibility for both basic and translational research.
-
Mechanisms of Spiroplasma eriocheiris Entry into Drosophila
2026-05-14
Wei et al. (2019) reveal that Spiroplasma eriocheiris invades Drosophila S2 cells primarily via clathrin-mediated endocytosis and macropinocytosis, leading to apoptosis and decreased cell viability. These findings clarify pathogen entry routes in invertebrate models and highlight cytoskeletal and endocytic pathways as potential intervention points.
-
PLGA-Based Nano-Adjuvant Boosts Mucosal Immunity in Chicks
2026-05-14
This study introduces a PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) that significantly enhances both mucosal and systemic immune responses against H9N2 avian influenza in chicks. Through targeted intestinal delivery and sustained antigen release, it addresses the limitations of traditional vaccine adjuvants, supporting improved vaccine efficacy.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Protocol and QC Guide
2026-05-13
The Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003) provides a rapid, fluorescence-based workflow for distinguishing apoptotic stages in mammalian cells. It is best suited for research applications requiring early apoptosis detection or cell death pathway analysis using flow cytometry or fluorescence microscopy. The kit is not intended for diagnostic or clinical use and should not be used outside the recommended cell types and detection platforms.
-
Paroxetine Mesylate: Multi-Target Mechanisms and Oncology Pr
2026-05-13
Explore the advanced pharmacological mechanisms of Paroxetine Mesylate, a selective serotonin reuptake inhibitor, and its emerging role as a multi-target agent in oncology. This article delivers a unique, evidence-based perspective that bridges molecular pharmacology with translational cancer research.
-
Lamotrigine: Advanced Protocols for Epilepsy and Cardiac Res
2026-05-12
Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) from APExBIO unlocks robust, reproducible workflows for studying sodium channel and serotonin signaling in neurological and cardiac models. This guide delivers protocol enhancements, troubleshooting strategies, and practical insights rooted in high-throughput BBB assays and validated reference data.
-
Diethylmaleate in Oxidative Stress and Resistance Research
2026-05-12
Diethylmaleate is a powerful tool for dissecting antioxidant defense mechanisms and modeling resistance to oxidative stress in both cell and organismal assays. Recent studies highlight its precision in glutathione depletion and GST inhibition, enabling breakthroughs in toxicology and pest management research.
-
Digoxin as a Na+/K+ ATPase Pump Inhibitor: Protocols & Innov
2026-05-11
Digoxin stands at the intersection of cardiovascular and virology research, offering potent Na+/K+ ATPase inhibition for both arrhythmia models and cell-type specific viral assays. This article equips scientists with actionable workflows, troubleshooting strategies, and translational insights leveraging APExBIO's high-purity Digoxin.
-
5-HT Reuptake Blockade Triggers Pyroptosis in BRAF V600E Mel
2026-05-11
Li et al. identify paroxetine hydrochloride as an inducer of pyroptosis and anti-tumor immunity in BRAF V600E-mutated melanoma by disrupting histone serotonylation and DNA repair. The study demonstrates the therapeutic potential of repurposing antidepressants for resistant melanoma, with implications for proteostasis and protein extraction workflows.
-
Hydrazide-Based VEGFR-2 Inhibitors: Advances in Antiangiogen
2026-05-10
This study reports the design, synthesis, and evaluation of 53 novel hydrazide-based VEGFR-2 inhibitors, highlighting SA7 as a lead compound with potent antiangiogenic and antiproliferative activity. The research underscores the therapeutic relevance of targeting VEGFR-2 in cancer biology and establishes new chemical tools comparable to established agents such as sorafenib.
-
Fludarabine: DNA Synthesis Inhibitor Workflows for Oncology
2026-05-09
Fludarabine’s precise DNA synthesis inhibition unlocks reproducible cell cycle arrest and apoptosis in advanced leukemia and multiple myeloma research. This guide delivers actionable workflow enhancements, troubleshooting strategies, and translational insights, leveraging APExBIO’s rigorously characterized Fludarabine for next-generation oncology studies.
-
Gamma-linolenic Acid (GLA): Precision Immunomodulation in An
2026-05-08
Explore how gamma-linolenic acid (GLA) advances anti-inflammatory research with precision immunomodulation. This article uncovers unique mechanistic insights and assay strategies, connecting GLA's pharmacology to practical, evidence-based applications.
-
HDAC Inhibition Reverses EBV-Driven Plasticity in NPC Cells
2026-05-08
This study uncovers how EBV-induced dedifferentiation in nasopharyngeal carcinoma (NPC) is mediated by LMP1-driven epigenetic repression of CEBPA. It demonstrates that histone deacetylase (HDAC) inhibition can restore differentiation, offering a mechanistic rationale for differentiation therapy in solid tumors.